Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

ClinicalTrials.gov ID: NCT00455546

Public ClinicalTrials.gov record NCT00455546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PLASMA Trial: Phospholipase Levels And Serological Markers of Atherosclerosis: A Dose-Response Clinical Pharmacology Study of A-002 In Subjects With Stable Coronary Artery Disease

Study identification

NCT ID
NCT00455546
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Anthera Pharmaceuticals
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

  • A-002 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2007
Primary completion
Not listed
Completion
Aug 31, 2007
Last update posted
Feb 1, 2010

2007

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Mobile Heart Specialists Mobile Alabama 36608
Sonoran Health Specialists Scottsdale Arizona 85260
Central Arkansas Research Hot Springs Arkansas 71913
Broward General Medical Center Fort Lauderdale Florida 33316
Not listed Hudson Florida
Charlotte Cardiovascuar Research Port Charlotte Florida 339521
Florida Cardiovascular Institute Tampa Florida 33609
Augusta Cardiology Clinic, PC Augusta Georgia 30901
Louisville Cardiology Medical Group Louisville Kentucky 40207
Maine Research Associates Auburn Maine 04210
University of Michigan Ann Arbor Michigan 48106
Henry Ford Hospital Detroit Michigan 48202
United Medical Associates Binghamton New York 13901
Regional Clinical Research, Inc. Endwell New York 13760
Cardiology, PC Syracuse New York 13210
Oklahoma Cardiovascular and Hypertension Center Oklahoma City Oklahoma 73132
Lehigh Valley Hospital Allentown Pennsylvania 18105
Not listed Camp Hill Pennsylvania
Black Hills Clinical Research Center Rapid City South Dakota 57701
Austin Heart Austin Texas 78705
Cardiopulmonary Research Science and Technology Institute Dallas Texas 75230
Clinical Research Associates of Tidewater Norfolk Virginia 23507
Winsconin Heart, SC Madison Wisconsin 53715

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00455546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 1, 2010 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00455546 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →